Patents by Inventor Kim James

Kim James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050234097
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: March 16, 2005
    Publication date: October 20, 2005
    Inventors: Alan Brown, Charlotte Lane, Paul Glossop, David Price, Russell Lewthwaite, Mark Bunnage, Kim James, Graham Lunn
  • Publication number: 20050222128
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: March 21, 2005
    Publication date: October 6, 2005
    Inventors: Alan Brown, Mark Bunnage, Charlotte Lane, Russell Lewthwaite, Paul Glossop, Kim James, David Price
  • Publication number: 20050215542
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds of the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: March 21, 2005
    Publication date: September 29, 2005
    Inventors: Alan Brown, Mark Bunnage, Charlotte Lane, Russell Lewthwaite, Paul Glossop, Kim James, David Price
  • Publication number: 20050215590
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: March 21, 2005
    Publication date: September 29, 2005
    Inventors: Alan Brown, Mark Bunnage, Charlotte Lane, Russell Lewthwaite, Paul Glossop, Kim James, David Price
  • Publication number: 20050182091
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: January 19, 2005
    Publication date: August 18, 2005
    Inventors: Alan Brown, Mark Bunnage, Paul Glossop, Kim James, Charlotte Lane, Russel Lewthwaite, Ian Moses, David Price, Nicholas Thomson
  • Publication number: 20050171147
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: January 19, 2005
    Publication date: August 4, 2005
    Inventors: Alan Brown, Kim James, Charlotte Lane, Ian Moses, Nicholas Thomson
  • Patent number: 6897306
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 24, 2005
    Assignee: Pfizer Products, Inc.
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • Patent number: 6821972
    Abstract: Compounds of formula (I): and their salts, solvates, hydrates and prodrugs are useful PCP inhibitors, processes for making the same, compositions comprising the same, and methods of treating a PCP-mediated condition or disease using the same.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: November 23, 2004
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Paul Vincent Fish, Kim James, Gavin Alistar Whitlock
  • Publication number: 20040142986
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: December 9, 2003
    Publication date: July 22, 2004
    Inventors: Usa Datta, Paul Vincent Fish, Kim James, Gavin Alistair Whitlock
  • Patent number: 6716861
    Abstract: Compounds of formula (I): wherein the substituents are as defined herein, and their salt, solvates, and prodrugs are procollagen C-proteinase (PCP) inhibitors useful in treating conditions mediated by PCP.
    Type: Grant
    Filed: December 12, 2001
    Date of Patent: April 6, 2004
    Assignee: Pfizer, Inc.
    Inventors: Usa Datta, Paul Vincent Fish, Kim James, Gavin Alistair Whitlock
  • Publication number: 20030119807
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: July 16, 2002
    Publication date: June 26, 2003
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • Publication number: 20030069291
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: March 29, 2002
    Publication date: April 10, 2003
    Inventors: Simon Bailey, Paul Vincent Fish, Kim James, Gavin Alistar Whitlock
  • Patent number: 6448278
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: September 10, 2002
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson
  • Patent number: 6384070
    Abstract: Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R1 and R2 are optional substituents and independently represent C1-6 alkyl, C2-6 alkenyl, optionally substituted by CO2H or CO2(C1-6 alkyl), C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr1, (CH2)mHet1, (CH2)mCONR7R8, (CH2)mCO2R8, O(CH2)qCO2R8, (CH2)mCOR8, (CH2)mOR8, O(CH2)pOR8, (CH2)mNR7R8, CO2(CH2)qNR7R8, (CH2)mCN, S(O)nR8, SO2NR7R8, CONH(CH2)mAr1 or CONH(CH2)mHet1; R3 represents H, C1-6 alkyl, (CH2)pNR9R10, SO2R10, SO2NR9R10, (CH2)mCO2R10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR9R10, (CH2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH2)pOR10; R4 represents H or C1-6 alkyl; R5 represents H or OH; R6 represents phenyl optionally fused to a heterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar2 or Het2; Z represents CO2H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar3, CO2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO2(CH2)qAr3 or
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: May 7, 2002
    Assignee: Pfizer Inc.
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6306852
    Abstract: Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R1 and R2 are optional substituents and independently represent C1-6 alkyl, C2-6 alkenyl, optionally substituted by CO2H or CO2(C1-6 alkyl), C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr1, (CH2)mHet1, (CH2)mCONR7R8, (CH2)mCO2R8, O(CH2)qCO2R8, (CH2)mCOR8, (CH2)mOR8, O(CH2)pOR8, (CH2)mNR7R8, CO2(CH2)qNR7R8, (CH2)mCN, S(O)nR8, SO2NR7R8, CONH(CH2)mAr1 or CONH(CH2)mHet1; R3 represents H, C1-6 alkyl, (CH2)pNR9R10, SO2R10, SO2NR9R10, (CH2)mCO2R10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR9R10, (CH2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH2)pOR10; R4 represents H or C1-6 alkyl; R5 represents H or OH; R6 represents phenyl optionally fused to a herterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar2 or Het2; Z represents CO2H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar3, CO2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO2(CH2)qAr3 o
    Type: Grant
    Filed: April 24, 2000
    Date of Patent: October 23, 2001
    Assignee: Pfizer Inc.
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Publication number: 20010021718
    Abstract: 1
    Type: Application
    Filed: December 13, 2000
    Publication date: September 13, 2001
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson
  • Publication number: 20010014677
    Abstract: 1
    Type: Application
    Filed: January 9, 2001
    Publication date: August 16, 2001
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6211223
    Abstract: The invention provides S-(+)-3-{1-(1,3-benzodioxol-5-yl)-2-[(2-methoxy-4-methylphenyl)sulfonylamino]-2-oxoethyl}-1-methyl-1H-indole-6-carboxylic acid, which is substantially free from its (R)-(−)-enantiomer, and pharmaceutically acceptable derivatives thereof. The compounds are useful in the treatment of inter alia acute renal failure, restenosis and pulmonary hypertension.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: April 3, 2001
    Assignee: Pfizer Inc.
    Inventors: Stephen Challenger, Kevin Neil Dack, Andrew Michael Derrick, Roger Peter Dickinson, David Ellis, Yousef Hajikarimian, Kim James, David James Rawson
  • Patent number: 6136843
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: October 24, 2000
    Assignee: Pfizer Inc
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6108632
    Abstract: A transaction support apparatus is used by one or more human transaction operators, each provided with a telephone. It includes a speech recognition device having: a speech input coupled to receive a speech signal input to a telephone by a transactiob operator, a speech recognition processor arranged to recognize predetermined transaction parameters within the speech signal; and a parameter output at which the speech recognition device is arranged to make values of the parameters thus recognized available.
    Type: Grant
    Filed: April 3, 1998
    Date of Patent: August 22, 2000
    Assignee: British Telecommunications public limited company
    Inventors: Anthony Andrew Reeder, Kim James Fisher, Michael Anthony Gell, Laurence Daniel Bradley